26
Nov
2024

Saptagir Laboratories Pvt. Ltd.

Exhibitor at CPHI & PMEC India 2024 stand RH.F34
About Us

We, Saptagir Laboratories make high-quality APIs, niche intermediates, specialty chemicals and reagents. We are trusted suppliers to 5 of the top 10 global generics companies. 

Incorporated in 2016, we are a constituent unit of the SAPTAGIR GROUP with a history of more than 30 years and the largest single manufacturer of Synthetic Camphor and Aromatic Terpene chemicals in India and a leading supplier globally. We are the world’s only fully backward integrated manufacturers of Camphor Sulphonic Acid.


  • IN
  • 2021
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Intermediates Manufacturer
Contact info
Event information
CPHI & PMEC India 2024
  • 26 Nov 2024 - 28 Nov 2024
  • India Expo Centre, Greater Noida, Delhi NCR
  • Visit us at stand RH.F34

Products Featured at CPHI & PMEC India 2024

  • Zavegepant

    Product Zavegepant

    Zavegepant is a medication used for the treatment of migraine. Zavegepant is a calcitonin gene-related peptide receptor antagonist. It is sprayed into the nose.
  • Camphor

    Product Camphor

    Camphor is an antibacterial, antifungal, and anti-inflammatory agent, used to treat skin conditions, improve respiratory function, and relieve pain.
  • Edoxaban

    Product Edoxaban

     Edoxaban is used to lower the risk of stroke caused by a blood clot in people with a heart rhythm disorder called atrial fibrillation.
  • Ezetimibe

    Product Ezetimibe

    Ezetimibe is a medication used to treat high blood cholesterol and certain other lipid abnormalities.
  • Opicapone

    Product Opicapone

     Opicapone is used to treat the symptoms of Parkinson's disease, a condition that causes low levels of dopamine in the brain. 
  • Tafamidis

    Product Tafamidis

    Tafamidis is a medication used to treat transthyretin-mediated amyloidosis, a certain type of heart failure.